Multivessel Coronary Artery Disease Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting multivessel coronary artery disease clinical trials across 11 countries. Studies span Not Applicable. Top locations include Vienna, Austria, Bad Nauheim, Germany, Bad Oeynhausen, Germany. Updated daily from ClinicalTrials.gov.


Multivessel Coronary Artery Disease Trials at a Glance

7 actively recruiting trials for multivessel coronary artery disease are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Vienna, Bad Nauheim, and Bad Oeynhausen. Lead sponsors running multivessel coronary artery disease studies include Centro Cardiologico Monzino, Imperial College London, and American Heart of Poland.

Browse multivessel coronary artery disease trials by phase

Treatments under study

About Multivessel Coronary Artery Disease Clinical Trials

Looking for clinical trials for Multivessel Coronary Artery Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Multivessel Coronary Artery Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Multivessel Coronary Artery Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Insights From the FAST-TRACK CABG Trial: a Clinical Outcome Study in Patient With Previous Surgical Revascularization for Complex Three-vessel or Left Main Coronary Artery Disease Based on Coronary Computed Tomography Angiogram, and Fractional Flow Reserve Derived by Computed Tomography

Multivessel Coronary Artery Disease
Centro Cardiologico Monzino100 enrolled1 locationNCT07628270
Recruiting
Not Applicable

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Heart FailureCoronary Artery DiseaseCoronary Artery Disease (CAD)+5 more
University Medical Center Groningen358 enrolled1 locationNCT07269366
Recruiting
Not Applicable

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Acute Coronary SyndromeMultivessel Coronary Artery Disease
American Heart of Poland1,000 enrolled7 locationsNCT01311323
Recruiting
Not Applicable

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Cardiogenic ShockCoronary Artery DiseaseChronic Heart Failure+4 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation100 enrolled1 locationNCT07149714
Recruiting

STICH3C Cardiac Magnetic Resonance Observational Study

Multivessel Coronary Artery DiseaseIschemic Left Ventricle Systolic Dysfunction
Weill Medical College of Cornell University200 enrolled9 locationsNCT07133984
Recruiting
Not Applicable

Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina

Stable AnginaMultivessel Coronary Artery Disease
Imperial College London60 enrolled9 locationsNCT06400290
Recruiting
Not Applicable

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Multivessel Coronary Artery DiseaseNon-ST Elevation Myocardial Infarction
Leipzig Heart Science gGmbH3,390 enrolled58 locationsNCT05786131